ARCHIVES

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

ASCO Conquer Cancer Foundation Awards $6 Million To Researchers

April 22, 2011

Cancer Control Contractors Severally Criticized In Merit Peer Review; Inadequate Reports Cited

May 28, 1976

Emory Cancer Experiment Launched Into Space

January 17, 2003

In Brief: ACS Begins Narrowing List of Job Applicants; IL-2 Gets BRM Ok; Pitot Resigns McArdle Post

January 31, 1992

In Brief: FASEB Report On Diet and Cancer Mortality Available; Don Poppke AO of Nursing Center

March 6, 1987

NCI Ends Brash Foray Into the News Business—Emails Tell the Story of the NCI Cancer Bulletin

February 1, 2013